Analyst firms · BofA Securities · FULC
BofA Securities FULC price target and rating history
Fulcrum Therapeutics Inc. (FULC) · Health Care
BofA Securities rates Fulcrum Therapeutics Inc. (FULC) Underperform with a $2 price target, as of its latest action on Sep 12, 2024. It has published 4 rating actions on FULC since March 2022, including 2 upgrades and 2 downgrades. Across 5 firms with a FULC price target in the last 12 months, the median target is $3.
- Current rating
- Underperform
- Price target
- $2
- Median target, all firms
- $3
- Actions on FULC
- 4
BofA Securities price target on FULC
Every BofA Securities rating on FULC
- Sep 12, 2024
- Sep 9, 2024
- Feb 24, 2023
- Mar 3, 2022
How other firms rate FULC
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Piper Sandler | Neutral | $3 | Jun 2, 2026 |
| H.C. Wainwright | Neutral | $3 | Jun 2, 2026 |
| Leerink Partners | Market Perform | $4 | Jun 2, 2026 |
| Truist Securities | Hold | $4 | Jun 2, 2026 |
| Stifel | Hold | $3 | Jun 2, 2026 |
Questions about BofA Securities and FULC
- What is BofA Securities's price target for FULC?
- BofA Securities's latest stated price target for Fulcrum Therapeutics Inc. (FULC) is $2, from its action on Sep 12, 2024.
- What is BofA Securities's rating on FULC?
- BofA Securities rates FULC Underperform, a bearish rating, as of Sep 12, 2024.
- When did BofA Securities last change its view on FULC?
- On Sep 12, 2024, BofA Securities downgrades to Underperform from Neutral, price target $10 to $2.
- How does BofA Securities's FULC target compare with other analysts?
- Across 5 firms with a FULC price target in the last 12 months, the median target is $3.
More FULC rating histories
All BofA Securities ratingsFULC news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.